game earn real money
Screen tests aren’t just for movie stars
Kulgam/ Baramulla, Dec 7: Jammu and Kashmir launched a 100-day drive to end tuberculosis (TB) with Minister for Health and Medical Education, Social Welfare and Education, Sakeena Masood (Itoo) launching the campaign across J&K on Saturday. Virtually launching the 100-day campaign under the National TB Elimination Programme (NTEP) across J&K at Kashmir Skill and Simulation Centre, RIHFW Dhobiwan, Tangmarg in north Kashmir’s Baramulla district, the health minister said, “TB continues to be a major public health challenge in the country, but with determination, innovation, and a collective effort, we can overcome it.” She said that this campaign represents an unwavering commitment to achieving the vision of TB-free J&K. The minister underlined that over the next 100 days, the department would aim to accelerate TB detection, ensure timely treatment and promote awareness about preventive measures. She said that this was not just a government initiative but a people’s movement that calls for active participation from every corner of society. The health minister said that the present government was focused on reaching the unreached, establishing advanced healthcare facilities, strengthening diagnostics, enhancing community engagement and ensuring no one was left behind in the fight against TB. “With the support of healthcare workers, local stakeholders, and the people, the Health Department will achieve significant milestones during this campaign,” she said. MLA Beerwah Muhammad Shafi, MLA Gulmarg Farooq Ahmad Shah, and MLA Uri Sajjad Shafi commended the efforts of the health staff for their contributions and achievements. They reiterated their full support for the campaign, highlighting that the objective of this 100-day campaign was to accelerate efforts in eliminating TB, reaching every corner of the community, spreading awareness about the disease, and ensuring access to free and high-quality TB care. Joint Secretary, Ministry of Health and Family Welfare, Government of India, Meera Srivastava urged healthcare providers, industry leaders, corporate organisations, counsellors, media professionals, and citizens to collaborate in this effort. She emphasised the importance of ensuring that no one was left behind in the fight against TB, striving for a TB-free community where no child loses a parent, no student misses school, and no worker loses their livelihood due to TB. Srivastava reinforced that this 100-day campaign was not merely a health initiative but a commitment to building healthier and stronger communities. Director of Health Services, Kashmir, Dr Jehangir Bakshi along with all other participants took the TB Pledge, demonstrating a strong commitment to the elimination of tuberculosis in the Kashmir division. He said that the National Tuberculosis Elimination Programme (NTEP) in Kashmir had made remarkable progress. State Tuberculosis Officer, Kashmir, Dr Adhfar Yasien delivered the opening remarks on the 100-day intensified campaign for TB Elimination (Ni-kshay Shivir). She emphasised the significant importance of this campaign, noting that TB was not only a health issue but also a major social and economic burden, particularly affecting the most vulnerable segments of society. Dr Adhfar also highlighted that India accounts for approximately 27 percent of the world’s TB cases, emphasising the urgency of this ongoing fight. “TB continues to claim lives, disrupt families, and reduce the productivity of entire communities,” she said. Divisional Nodal Officer, National Health Mission (NHM), Dr Mushtaq Ahmad thanked all the visiting dignitaries and participants present in the occasion, who have dedicated themselves to this cause. He called on all to unite and ensure the success of this 100-day campaign, marking a major step toward a TB-free India and TB-Free Kashmir. Additional Deputy Commissioner, Baramulla and health functionaries from various districts of the Kashmir division were also present at the campaign launch. Three districts in Kashmir – Budgam, Anantnag, and Pulwama – have been declared TB-free. Additionally, two districts, Srinagar and Kupwara, have received gold certification under the Sub-National Certification and J&K has received a bronze medal in the same category. Over 15 million TB cases have been successfully treated since the start of the programme and significant improvements in detection and recovery rates have been achieved due to better diagnostic and treatment tools. Despite these advancements, challenges like stigma, late diagnosis, and treatment dropouts remain, and the 100-day campaign aims to directly address these issues through the involvement of all stakeholders. During this 100-day intensified campaign, health teams would focus on conducting active case findings by visiting high-risk and vulnerable populations, including malnourished individuals, diabetics, smokers, cancer patients, tribal communities, and other at-risk groups. The goal is to detect TB cases early, raise awareness about TB symptoms, prevention, and treatment, and provide continuous medical and psychological support to ensure successful recovery. Additionally, community leaders, NGOs, corporate organisations, counsellors, and health workers will be engaged to serve as ambassadors for change. After the event, two TB eradication vans were flagged off, one for district Srinagar, which was flagged off by the Director of Health Services, Kashmir, Dr Jahingir Bakshi, Chief Medical Officer, Srinagar, Dr Tahir Sajad, and District Tuberculosis Officer, Srinagar, Dr Abdul Roof, and the other for the district Baramulla was flagged off by Additional District Development Commissioner, Baramulla, Syed Qamar Sajad, Chief Medical Officer, Baramulla, Dr Mastoora Akhter, and District Tuberculosis Officer, Baramulla, Dr Hafizulla.UTAH VALLEY 77, WEST GEORGIA 74
Syria refutes propaganda claimsLaLiga: I’m angry – Raphinha slams Barça after 2-1 defeat to Las Palmas
How to party on this Christmas — without hurting the environmentUP: Far-right leader invokes 2002 Gujarat riots over Bangladesh minorities concernUTAH VALLEY 77, WEST GEORGIA 74
NoneJacksen Moni scores 18 to lead North Dakota State past Northern Colorado 82-70
SNYDER — This little village of 300 has become such a manufacturing powerhouse, its population more than doubles when the morning shifts start at the four factories lining the highway. One company alone employs 250 people making big aerial ladder trucks for fire departments all over North America. The town also boasts another firm making smaller fire engines, still another assembling specialty vehicles for the water well industry, as well as a new food processor. “We build some pretty cool stuff here,” said Jeff Hunke, who grew up in Snyder and owns and runs Hunke Manufacturing. “I mean, this little town puts aerial ladders in New York City.” Workers assemble fire apparatus at the Smeal facility in Snyder on Nov. 25. But Snyder isn’t the only place in Nebraska where manufacturing booms. Nebraska in recent years has been undergoing a bit of a manufacturing renaissance, with the 109,000 people currently employed in the industry representing a 23-year high. People are also reading... Nebraska’s manufacturing employment is up over 9% in the past five years alone, adding more than 9,000 jobs. That growth, by percentage, is nearly 16 times the national rate and one of the highest among the states. “There is clearly a lot of wind behind the sails of manufacturing in Nebraska,” Tim Carpenter, chief executive of David City trailer manufacturer Timpte, said during a recent manufacturing conference in Omaha. Industry officials and economists cite a number of reasons for the recent momentum. The state is strong in food processing, one of the fastest growing manufacturing sectors. It also boasts many agriculture-related durable goods manufacturers that have been boosted by a strong farm economy over the last decade. It’s believed Nebraska has also benefited from a national trend of American firms seeking to source more of their supplies domestically after the disruptions to worldwide supply chains caused by the 2020 pandemic. More than anything, the state has long enjoyed a stellar base of makers and creators who take pride that their products are not only made in America, but made in Nebraska. Manufacturing is the state’s second-largest industry after agriculture, with more than one in 10 Nebraska jobs in the sector. Many of the jobs are rooted in rural communities, manufacturers decades ago realizing they could find a strong blue-collar workforce in those areas — many of them kids who grew up working on farms. “The quality of the employees, the work ethic, provides a good asset for us,” said Mark Kreikemeier, president of Snyder’s Danko Emergency Equipment. Cheyenne Renter buffs the finish on a truck at Danko Emergency Equipment Co. in Snyder, on Nov. 25. The state’s central location, midway between coastal markets, and availability of cheap electricity and business tax incentives have also historically made Nebraska a productive place for making things. “Frankly, we have a lot of really good manufacturers in the state who are eager to grow,” said K.C. Belitz, director of the Nebraska Department of Economic Development. “So it’s been really impressive.” The impressive growth comes despite the labor shortage that has long plagued the state. The state chamber of commerce believes as many as 8,000 manufacturing jobs are currently going unfilled simply because firms can’t find the workers. “Here, we’re all fighting for the same employee,” Kreikemeier said. Kreikemeier and others say the situation has recently gotten a little better, thanks to a plethora of new apprenticeship and internship programs through local high schools and community colleges. That, too, has likely helped to propel some of the recent job growth. Now the industry’s impressive run could either be enhanced or tested with the upcoming change of administration in Washington. President-elect Donald Trump has vowed to boost American manufacturers by putting heavy tariffs on foreign imports, particularly from China. That would raise the price of products coming in from those countries and make American-made products more competitive. Some American manufacturers embrace the change as helping them compete against countries that are unfairly subsidizing their manufacturers. “We can go back to American-made parts, and get them on time, because today we're buying so much from China,” Danko’s Kreikemeier said. But most economists, and even some manufacturers, are skeptical of Trump’s plan. They say such tariffs would raise prices for consumers, risking more inflation and interest rate hikes. They also say new tariffs would inevitably invite retaliatory tariffs from other countries that would in turn make American exports less competitive. “If you can find an economist who thinks you should raise tariffs, give me a call,” said Creighton University economist Ernie Goss. “Two areas we do well in (in Nebraska) are agriculture and manufacturing, and both of them depend on free trade.” Decades of manufacturing declines before resurgence Between 1998 and 2009, Nebraska shed nearly 20% of its manufacturing jobs. It was part of a broader national slump that began in the late 1970s, largely fueled by increased automation, a rise of service jobs and globalization of production. In Nebraska, the decline was probably best symbolized in 2008. That’s when the owner of the 84-year-old Vise-Grips plant in DeWitt — the little town where the locking pliers had been invented — shuttered it and outsourced the production to China. Some 330 local residents were thrown out of work. It’s been said the deindustrialization that hammered blue-collar workers in recent decades helped fuel the rise of Trump’s Make America Great Again political movement. But the past manufacturing slump makes the recent resurgence in Nebraska all the more impressive. Manufacturing jobs in Nebraska were growing somewhat before the pandemic but then surged coming out of it. During 2022, Nebraska manufacturing employment jumped 4% — the biggest one-year increase since 1994. They’ve continued to rise on nearly a monthly basis — up another 2.8% so far this year. The 109,000 manufacturing jobs as of October were at their highest number in Nebraska since September 2001. The growth has also stood out nationally. Nebraska’s 9% growth in the industry since the end of 2019 compares to growth of about one-half of 1% nationally. One recent study ranked the state’s manufacturing jobs growth between 2020 and 2023 the sixth highest among all states, trailing only Nevada, Montana, Utah, Florida and Arizona. Iowa ranked 24th, with a fraction of Nebraska’s growth. Nebraska’s gains have come despite some recent weakening in the farm economy. They've also come even as some production tasks have become increasingly automated. Some Nebraska manufacturers say automation has actually been a force multiplier for them, machines handling some of the more rote and repetitive work and freeing up workers to perform higher-value tasks. “There’s growth in employment, growth in GDP, and growth in interest among young people on what a career in manufacturing looks like,” said Mike Johnson, who leads the Nebraska Chamber of Commerce and Industry’s efforts to boost manufacturing. A panel discussion at the chamber’s recent manufacturing conference focused on efforts to recruit and develop more workers. Snyder is a town with a large manufacturing footprint for a town of less than 300 people. The Nebraska Department of Education is preparing to roll out a new online portal that can match manufacturers looking for workers with school districts and students looking for such opportunities. Officials at Lozier, a builder of store shelves and fixtures that has long been an important employer in northeast Omaha, said they recognized years ago that with an aging Baby Boomer workforce, the company would need to get aggressive if it was going to have the workers it needs. So in 2012, Lozier partnered with Metropolitan Community College on an apprenticeship program in which the company provides candidates on-the-job training and pays for their schooling. Today, nearly a third of Lozier workers have come through the program. “After two years, they’ll have a degree, they’ll have experience and money in their pocket, and a job waiting for them,” said Lozier’s Ralph Kleinsmith. Good-paying jobs, too, he said — paying between $65,000 and $70,000 per year, with overtime. National studies show manufacturing workers generally earn more than comparable workers in the rest of the private sector, with a premium for those in highly-skilled niches. Besides good pay, the industry has much else to offer, industry advocates say. “What’s the coolest thing about manufacturing: We build stuff,” said Jim Townsend of Kawasaki in Lincoln, which this year celebrated 50 years of operations. According to data compiled by IndustrySelect, Omaha and Lincoln have the most manufacturing employees in Nebraska at 26,000 and 24,000 workers, respectively. Other big manufacturing cities include Grand Island (nearly 8,000) and Columbus (more than 5,000). But few Nebraska communities can claim more manufacturing firms or workers per capita than Snyder. The four manufacturers in town collectively employ almost 400 workers, drawing most of them from other towns and cities in a 60-mile radius. Snyder may be the only town of 300 that features rush hour traffic congestion, as at quitting time vehicles back up a quarter mile along Nebraska Highway 91 at its intersection with U.S. 275. The town’s proud manufacturing heritage can largely be traced to one man: Don Smeal. Smeal in 1955 founded a local repair shop for implements and equipment. Some time later, a man asked him to build a specialized derrick truck for use in the water well industry. Then in 1963, the Snyder rural fire district asked Smeal to build it a 42-foot ladder truck. Smeal Fire Apparatus Company was born. Smeal is no longer a local family-owned firm, acquired years ago by a national manufacturer. But it remains rooted in Snyder under the Smeal name, and three Smeal family members still work at the plant — one of them is Snyder’s mayor. Sparks flew and machinery roared on the production floor last week as workers took raw aluminum and steel and cut it, bent it, formed it, welded it and assembled it into bodies that would then be mounted on truck chassis. The complexities of a fire truck and all their gadgets mean jobs not just for welders, but plumbers and electricians, too. At the end of the line, a brightly painted new fire truck comes out, ready for delivery. “You’re not going to find a more cool product to build than a fire truck,” said Kevin Strudthoff, general manager of the Smeal facility, as he watched a woman on the line weld components into place. “It’s an opportunity for a Nebraska-made product to go out throughout the United States. When you talk to the folks on the floor, they do take pride in that.” Strudthoff said the company has about 20 more workers than it did a year ago, and could use 20 more if he could find them. Across the street from the Smeal plant is Hunke Manufacturing, a 30-employee firm which traces its roots to Smeal. A worker welds at Hunke Manufacturing in Snyder on Nov. 25 It was formed in 2012 when Smeal’s original derrick truck business was spun out. It’s now owned and run by Jeff Hunke, a grandson of Don Smeal, who proudly proclaims it the nation’s largest manufacturer of hoist vehicles for the water well service industry. Hunke said his roster of work orders has never been so full, so he can use a few more workers if he can find them. Not only does Hunke sell all over the country, it has an export business, too. Down the highway to the east of Smeal and Hunke is Danko, another spin-off from Smeal. In 1974, Dan Kreikemeier, who was Don Smeal’s first employee, started his own firefighting vehicle firm. His son now serves as president and the firm employs over 60 people, specializing in making smaller all-terrain trucks that can fight brush fires. Last month, Cheyenne Renter was giving a final buff to the paint job of a fire truck before adding the stripes and graphics. She said she loves being able to see the finished product and “knowing what you do helps people.” The newest manufacturer on the block in Snyder is Wonder Meats, which opened last year in a plant that had recently been vacated by Omaha Steaks. It now employs about 45 people producing Philly-steak beef and chicken products for wholesale. Its New Jersey-based owners are also looking to expand the plant. “I think the story of our little town and the industry it has is something to be very proud of,” said Marla Prenzlow, a longtime Snyder resident who now manages the plant. “I know Wonder Meats plans to have the same longevity the other businesses have achieved.” The Nestle Purina plant in Crete has been utilizing a new Boston Dynamics Robot Dog in its manufacturing area to prolong the life of their machines and prevent breakdowns. These industries had the biggest swings in job openings These industries had the biggest swings in job openings Job openings have been at some of their lowest levels nationally since February 2021 , Bureau of Labor Statistics data shows. However, openings remain elevated compared to the two years before the COVID-19 pandemic, with 8.1 million open jobs at the end of May 2024—about 1 million above pre-pandemic levels. While Americans still find themselves largely employed, their capacity to resign and switch jobs is quickly falling to levels before the Great Resignation, when the quit rate reached 3% at its peak in spring 2022. Across industries, employers continued adding jobs, upping employment by 272,000 in May , with the majority of gains in health care, government, and leisure and hospitality. The unemployment rate remained relatively consistent, measuring at 4%. Excess labor demand is declining , and the labor market is rebalancing, Conrad DeQuadros, a senior economic adviser at Brean Capital, told Reuters. For workers, this means less confidence in finding new employment outside their current jobs. For employers, it could mean tempering wage inflation as demand for labor slows. To discover which industries are driving the job market, Stacker used data from the Bureau of Labor Statistics' Job Openings and Labor Turnover report to see which industries added jobs in May and which saw openings shrink. Industries are ranked by the percent change in job openings from May 2023 to 2024 and appear from the largest decreases to the largest increases. Monthly data is preliminary. The BLS records job openings on the last business day of the month and calculates the rate as a percent of total employment plus job openings within the industry. The list below provides a snapshot of the economic activity across categories—retail, finance, construction, and more. You may also like: A look at the average consultant salary by industry #18. Retail trade - Total job openings, May 2024: 478,000 --- Annual change: -274,000 (down 36.4%) --- One-month change: -16,000 (down 3.2%) - Job openings rate: 3% #17. Accommodation and food services - Total job openings, May 2024: 771,000 --- Annual change: -374,000 (down 32.7%) --- One-month change: -147,000 (down 16%) - Job openings rate: 5.1% #16. Transportation, warehousing, and utilities - Total job openings, May 2024: 350,000 --- Annual change: -167,000 (down 32.3%) --- One-month change: +16,000 (up 4.8%) - Job openings rate: 4.7% #15. Wholesale trade - Total job openings, May 2024: 188,000 --- Annual change: -79,000 (down 29.6%) --- One-month change: -1,000 (down 0.5%) - Job openings rate: 3% #14. Nondurable goods manufacturing - Total job openings, May 2024: 174,000 --- Annual change: -54,000 (down 23.7%) --- One-month change: +17,000 (up 10.8%) - Job openings rate: 3.5% You may also like: Workers suffer the most injuries in these 25 jobs #13. Information - Total job openings, May 2024: 134,000 --- Annual change: -28,000 (down 17.3%) --- One-month change: +24,000 (up 21.8%) - Job openings rate: 4.2% #12. State and local education - Total job openings, May 2024: 295,000 --- Annual change: -47,000 (down 13.7%) --- One-month change: +26,000 (up 9.7%) - Job openings rate: 2.7% #11. Construction - Total job openings, May 2024: 339,000 --- Annual change: -38,000 (down 10.1%) --- One-month change: +2,000 (up 0.6%) - Job openings rate: 4% #10. Mining and logging - Total job openings, May 2024: 27,000 --- Annual change: -3,000 (down 10%) --- One-month change: +3,000 (up 12.5%) - Job openings rate: 4.2% #9. Real estate and rental and leasing - Total job openings, May 2024: 112,000 --- Annual change: -9,000 (down 7.4%) --- One-month change: -32,000 (down 22.2%) - Job openings rate: 4.3% You may also like: A tale of two nurses: How average travel nurse compensation compares to all US nurse salaries #8. Professional and business services - Total job openings, May 2024: 1.5 million --- Annual change: -112,000 (down 7%) --- One-month change: +44,000 (up 3.1%) - Job openings rate: 6.1% #7. Arts, entertainment, and recreation - Total job openings, May 2024: 151,000 --- Annual change: -5,000 (down 3.2%) --- One-month change: 0 (up 0%) - Job openings rate: 5.4% #6. Private educational services - Total job openings, May 2024: 184,000 --- Annual change: -6,000 (down 3.2%) --- One-month change: -34,000 (down 15.6%) - Job openings rate: 4.5% #5. Health care and social assistance - Total job openings, May 2024: 1.6 million --- Annual change: -43,000 (down 2.6%) --- One-month change: +78,000 (up 5%) - Job openings rate: 6.8% #4. Federal government - Total job openings, May 2024: 176,000 --- Annual change: +2,000 (up 1.1%) --- One-month change: +37,000 (up 26.6%) - Job openings rate: 5.5% You may also like: As more women are diagnosed with ADHD, here's how their work environment can set them up for success #3. Finance and insurance - Total job openings, May 2024: 325,000 --- Annual change: +25,000 (up 8.3%) --- One-month change: +5,000 (up 1.6%) - Job openings rate: 4.6% #2. State and local government - Total job openings, May 2024: 615,000 --- Annual change: +61,000 (up 11%) --- One-month change: +117,000 (up 23.5%) - Job openings rate: 6% #1. Durable goods manufacturing - Total job openings, May 2024: 428,000 --- Annual change: +63,000 (up 17.3%) --- One-month change: +97,000 (up 29.3%) - Job openings rate: 5% #18. Federal government - Total job openings, June 2024: 106,000 --- Annual change: -58,000 (down 35.4%) --- One-month change: -62,000 (down 36.9%) - Job openings rate: 3.4% #17. Mining and logging - Total job openings, June 2024: 20,000 --- Annual change: -9,000 (down 31.0%) --- One-month change: -6,000 (down 23.1%) - Job openings rate: 3.1% #16. Construction - Total job openings, June 2024: 295,000 --- Annual change: -119,000 (down 28.7%) --- One-month change: -71,000 (down 19.4%) - Job openings rate: 3.5% #15. Retail trade - Total job openings, June 2024: 549,000 --- Annual change: -159,000 (down 22.5%) --- One-month change: +43,000 (up 8.5%) - Job openings rate: 3.4% #14. Nondurable goods manufacturing - Total job openings, June 2024: 164,000 --- Annual change: -44,000 (down 21.2%) --- One-month change: -11,000 (down 6.3%) - Job openings rate: 3.3% You may also like: 20 of the highest-paying cities for travel nurses #13. Information - Total job openings, June 2024: 112,000 --- Annual change: -30,000 (down 21.1%) --- One-month change: -25,000 (down 18.2%) - Job openings rate: 3.6% #12. Wholesale trade - Total job openings, June 2024: 245,000 --- Annual change: -54,000 (down 18.1%) --- One-month change: +47,000 (up 23.7%) - Job openings rate: 3.8% #10. Durable goods manufacturing - Total job openings, June 2024: 323,000 --- Annual change: -47,000 (down 12.7%) --- One-month change: -88,000 (down 21.4%) - Job openings rate: 3.8% #8. Health care and social assistance - Total job openings, June 2024: 1.6 million --- Annual change: -137,000 (down 7.8%) --- One-month change: -62,000 (down 3.7%) - Job openings rate: 6.7% #7. Transportation, warehousing, and utilities - Total job openings, June 2024: 406,000 --- Annual change: -31,000 (down 7.1%) --- One-month change: +62,000 (up 18.0%) - Job openings rate: 5.3% #6. Professional and business services - Total job openings, June 2024: 1.5 million --- Annual change: -43,000 (down 2.8%) --- One-month change: -27,000 (down 1.8%) - Job openings rate: 6.1% #5. Finance and insurance - Total job openings, June 2024: 308,000 --- Annual change: -4,000 (down 1.3%) --- One-month change: -39,000 (down 11.2%) - Job openings rate: 4.4% #2. State and local education - Total job openings, June 2024: 290,000 --- Annual change: +14,000 (up 5.1%) --- One-month change: +24,000 (up 9.0%) - Job openings rate: 2.6% #1. State and local government - Total job openings, June 2024: 698,000 --- Annual change: +34,000 (up 5.1%) --- One-month change: +94,000 (up 15.6%) - Job openings rate: 6.8% The business news you need Get the latest local business news delivered FREE to your inbox weekly.Palmer Luckey, the founder of Oculus, is positioning Anduril Industries—his Southern California startup defense firm—as a challenger to military-industrial giants like Lockheed Martin, Northrop Grumman, Boeing, and General Dynamics. Anduril announced on Wednesday a strategic partnership with Sam Altman's OpenAI to develop and deploy advanced artificial intelligence for national security missions. " By bringing together OpenAI's advanced models with Anduril's high-performance defense systems and Lattice software platform, the partnership aims to improve the nation's defense systems that protect U.S. and allied military personnel from attacks by unmanned drones and other aerial devices ," the startup wrote in a statement. Introducing: Roadrunner, a compact VTOL drone powered by twin thrust-vectored turbojet engines with extraordinary speed, range, and payload capacity. & Roadrunner-M, a radical new low-cost weapon that allows for unprecedented tactics against powerful threats. pic.twitter.com/2C7Ga0h1Hf The war in Ukraine and the broadening conflicts across the Middle East have shocked military advisors in recent years due to the proliferation of aerial threats from both unmanned systems and manned platforms, which have had devastating impacts. We've all seen the shocking kamikaze drone footage posted on X, showing drones neutralizing commercial vessels in the southern Red Sea or the Gulf of Aden, as well as suicide drones hunting soldiers in Ukraine. Anduril and OpenAI's strategic partnership will focus on upgrading America's counter-unmanned aircraft systems "to detect, assess and respond potentially lethal aerial threats in real-time," according to the startup, adding, "As part of the new initiative, Anduril and OpenAI will explore how leading edge AI models can be leveraged to rapidly synthesize time-sensitive data, reduce the burden on human operators, and improve situational awareness." Anduril continued: The accelerating race between the United States and China to lead the world in advancing AI makes this a pivotal moment. If the United States cedes ground, we risk losing the technological edge that has underpinned our national security for decades. The decisions made now will determine whether the United States remains a leader in the 21st century or risks being outpaced by adversaries who don't share our commitment to freedom and democracy and would use AI to threaten other countries. Brian Schimpf, co-founder & CEO of Anduril, released this statement: "Anduril builds defense solutions that meet urgent operational needs for the US and allied militaries. Our partnership with OpenAI will allow us to utilize their world-class expertise in artificial intelligence to address urgent Air Defense capability gaps across the world. Together, we are committed to developing responsible solutions that enable military and intelligence operators to make faster, more accurate decisions in high-pressure situations." OpenAI's Altman said: "OpenAI builds AI to benefit as many people as possible, and supports US-led efforts to ensure the technology upholds democratic values. Our partnership with Anduril will help ensure OpenAI technology protects US military personnel, and will help the national security community understand and responsibly use this technology to keep our citizens safe and free." Luckey is leveraging his Silicon Valley background to disrupt the defense sector. And apparently, Altman is on board, too. Recall what President-elect Trump said in July.... Trump: "I will build an Iron Dome over our country." pic.twitter.com/jrhLmL1bdC ChatGPT missiles next?
Escape Simulator 2 announced with promises of Dracula's castle and an improved escape room editorLOUISVILLE, Ky. (AP) — Landin Hacker scored 21 points as Bellarmine beat NAIA-member Brescia 94-66 on Saturday. Hacker finished 7 of 11 from 3-point range for the Knights (3-7). Ben Johnson scored 17 points while going 6 of 13 (5 for 12 from 3-point range) and added six assists. Dylan Branson shot 5 of 7 from the field and 2 for 3 from the line to finish with 12 points, while adding 10 rebounds. Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Get updates and player profiles ahead of Friday's high school games, plus a recap Saturday with stories, photos, video Frequency: Seasonal Twice a week
Inside Alistair Johnston’s crazy career from live TV transfers to Dolly Parton’s hometown & signing new Celtic contractRevolutionizing Care: Meet the Next-Gen Robot
CHICAGO (AP) — In the days after the presidential election, Sadie Perez began carrying pepper spray with her around campus. Her mom also ordered her and her sister a self-defense kit that included keychain spikes, a hidden knife key and a personal alarm. It’s a response to an emboldened fringe of right-wing “manosphere” influencers who have seized on Republican Donald Trump ’s presidential win to justify and amplify misogynistic derision and threats online. Many have appropriated a 1960s abortion rights rallying cry, declaring “Your body, my choice” at women online and on college campuses. For many women, the words represent a worrying harbinger of what might lie ahead as some men perceive the election results as a rebuke of reproductive rights and women’s rights. “The fact that I feel like I have to carry around pepper spray like this is sad,” said Perez, a 19-year-old political science student in Wisconsin. “Women want and deserve to feel safe.” Isabelle Frances-Wright, director of technology and society at the Institute for Strategic Dialogue, a think tank focusing on polarization and extremism, said she had seen a “very large uptick in a number of types of misogynistic rhetoric immediately after the election,” including some “extremely violent misogyny.” “I think many progressive women have been shocked by how quickly and aggressively this rhetoric has gained traction,” she said. The phrase “Your body, my choice” has been largely attributed to a post on the social platform X from Nick Fuentes, a Holocaust-denying white nationalist and far-right internet personality who dined at Trump's Mar-a-Lago club in Florida two years ago. In statements responding to criticism of that event, Trump said he had “never met and knew nothing about” Fuentes before he arrived. Mary Ruth Ziegler, a law professor at the University of California, Davis School of Law, said the phrase transforms the iconic abortion rights slogan into an attack on women’s right to autonomy and a personal threat. “The implication is that men should have control over or access to sex with women,” said Ziegler, a reproductive rights expert. Fuentes' post had 35 million views on X within 24 hours, according to a report by Frances-Wright's think tank, and the phrase spread rapidly to other social media platforms. Women on TikTok have reported seeing it inundate their comment sections. The slogan also has made its way offline with boys chanting it in middle schools or men directing it at women on college campuses, according to the Institute for Strategic Dialogue report and social media reports. One mother said her daughter heard the phrase on her college campus three times, the report said . School districts in Wisconsin and Minnesota have sent notices about the language to parents. T-shirts emblazoned with the phrase were pulled off Amazon. Perez said she has seen men respond to shared Snapchat stories for their college class with “Your body, my choice.” “It makes me feel disgusted and infringed upon,” she said. “... It feels like going backwards.” Misogynistic attacks have been part of the social media landscape for years. But Frances-Wright and others who track online extremism and disinformation said language glorifying violence against women or celebrating the possibility of their rights being stripped away has spiked since the election. Online declarations for women to “Get back in the kitchen” or to “Repeal the 19th,” a reference to the constitutional amendment that gave women the right to vote, have spread rapidly. In the days surrounding the election, the extremism think tank found that the top 10 posts on X calling for repeal of the 19th Amendment received more than 4 million views collectively. A man holding a sign with the words “Women Are Property” sparked an outcry at Texas State University . The man was not a student, faculty or staff, and was escorted off campus, according to the university’s president . The university is “exploring potential legal responses,” he said. Anonymous rape threats have been left on the TikTok videos of women denouncing the election results. And on the far-flung reaches of the web, 4chan forums have called for “rape squads” and the adoption of policies in “The Handmaid’s Tale,” a dystopian book and TV series depicting the dehumanization and brutalization of women. “What was scary here was how quickly this also manifested in offline threats,” Frances-Wright said, emphasizing that online discourse can have real-world impacts. Previous violent rhetoric on 4chan has been connected to racially motivated and antisemitic attacks, including a 2022 shooting by a white supremacist in Buffalo that killed 10 people . Anti-Asian hate incidents also rose as politicians, including Trump , used words such as “Chinese virus” to describe the COVID-19 pandemic. And Trump’s language targeting Muslims and immigrants in his first campaign correlated with spikes in hate speech and attacks on these groups, Frances-Wright said. The Global Project Against Hate and Extremism reported similar rhetoric, with “numerous violent misogynistic trends” gaining traction on right-wing platforms such 4chan and spreading to more mainstream ones such as X since the election. Throughout the presidential race, Trump’s campaign leaned on conservative podcasts and tailored messaging toward disaffected young men . As Trump took the stage at the Republican National Convention over the summer, the song “It’s A Man’s Man’s Man’s World” by James Brown blared from the speakers. One of several factors to his success this election was modestly boosting his support among men , a shift concentrated among younger voters, according to AP VoteCast, survey of more than 120,000 voters nationwide. But Trump also won support from 44% of women age 18 to 44, according to AP VoteCast. To some men, Trump's return to the White House is seen as a vindication, gender and politics experts said. For many young women, the election felt like a referendum on women’s rights and Democratic Vice President Kamala Harris ’ loss felt like a rejection of their own rights and autonomy. “For some of these men, Trump’s victory represents a chance to reclaim a place in society that they think they are losing around these traditional gender roles,” Frances-Wright said. None of the current online rhetoric is being amplified by Trump or anyone in his immediate orbit. But Trump has a long history of insulting women , and the spike in such language comes after he ran a campaign that was centered on masculinity and repeatedly attacked Harris over her race and gender . His allies and surrogates also used misogynistic language about Harris throughout the campaign. “With Trump’s victory, many of these men felt like they were heard, they were victorious. They feel that they have potentially a supporter in the White House,” said Dana Brown, executive director of the Pennsylvania Center for Women and Politics. Brown said some young men feel they’re victims of discrimination and have expressed mounting resentment for successes of the women’s rights movement, including #MeToo . The tension also has been influenced by socioeconomic struggles. As women become the majority on college campuses and many professional industries see increasing gender diversity, it has “led to young men scapegoating women and girls, falsely claiming it’s their fault they’re not getting into college anymore as opposed to looking inward,” Brown said. Perez, the political science student, said she and her sister have been leaning on each other, their mother and other women in their lives to feel safer amid the online vitriol. They text each other to make sure they got home safely. They have girls' nights to celebrate wins, including a female majority in student government at their campus in the University of Wisconsin system. “I want to encourage my friends and the women in my life to use their voices to call out this rhetoric and to not let fear take over,” she said. The Associated Press receives support from several private foundations to enhance its explanatory coverage of elections and democracy. See more about AP’s democracy initiative here . The AP is solely responsible for all content.
Ooredoo Stars League: Al Khor shock Al Duhail for a famous ‘first’ win
Best Bets for NCAA Basketball Picks Against the Spread for Friday, November 22Three reasons why Andy Murray’s appointment as Novak Djokovic’s coach could be a ‘masterstroke’
Joe Rogan claims a ‘media psy-op’ is responsible for people having a negative view of Trump
CHICAGO (AP) — Two-time NBA scoring champion Joel Embiid returned to the Philadelphia 76ers' starting lineup against the Chicago Bulls on Sunday. After missing his first seven shots and ambling deliberately in his left knee brace in the first quarter, the 2023 MVP went on a tear to propel the Sixers to a 108-100 win over the Chicago Bulls. Embiid connected on eight of his next 10 shots in the second quarter for his first 19 points of the game, which lifted Philadelphia to a 62-50 halftime lead. The Sixers stretched it to 19 before holding on for their fourth win in five games, and Embiid finished with 31. “I just got lucky and started making shots,” Embiid deadpanned when he talked to reporters almost 90 minutes after the game. “We just missed shots and we adjusted and we got them in.” Embiid, a seven-time All-Star, added 12 rebounds in his fifth game this season. The 7-foot center had missed the previous seven games because of knee injuries and a three-game suspension for pushing a sports columnist. Embiid finished slightly above his career average of nearly 27.8 points per game in 33 minutes. The Sixers don't play again until Friday thanks to the NBA Cup, so coach Nick Nurse planned to give his star ample work Sunday with a break and recovery time ahead. “All of a sudden he certainly caught fire there with a little bit of variety,” Nurse said. “I know a lot of it seemed like foul-line jumpers, which it was. He snuck in a roll or two and a couple of post-ups. It gave us a lot of confidence.” The Sixers trailed 33-23 after the first quarter. Behind Embiid and a 16-0 run in the second, they took the lead for good. Chicago got within four points twice in the fourth, but Philadelphia closed it out. “We guarded really well and we rebounded extremely well at both ends,” Nurse said. Tyrese Maxey got his first career triple-double as part of the winning formula and clicked with Embiid. Maxey finished with 25 points, 14 assists and 11 rebounds. “It was great, that's who he is,” Maxey said of Embiid. “After he got in the game it's easy, it was easier, man. There was a lot more space out there.” The All-Star trio of Embiid, Maxey and Paul George (12 points) played together for only the second game this season. “Obviously we've got the connection,” Embiid said. "We know when things are not going right, what we need to do. Now it's up to us to make the shots and the plays. “After that first quarter, it just felt like we needed to take more of an ownership as far as getting us back in the game. They're great players.” AP NBA: https://apnews.com/hub/nbaMarilyn J. Lopez
I have the same thought a lot of mornings when I look in the mirror. The bank insisted I confirm my identity before I could access our account — all because I made one teeny tiny typo entering the passcode. Flustered and in a hurry, but not one to ever make the same mistake twice, I made a different typo on my next try. I was automatically routed to the three-question “How Good Is Your Memory?” game. Where did you and your spouse first meet? What was your favorite pureed vegetable as an infant? What was your great, great, great maternal grandfather’s blood type? I failed that, too. I guess carrots was the wrong answer. I had to go to the bank in person to unfreeze the account. The teller asked if I had any additional identification. Just so you know, the bank will not accept an appendectomy scar from when you were a child as additional identification. The verification requests that I don’t mind are the ones that ask me to enter a code sent by text or email. I like these. They are good memory tests to see if I can flip between screens and still remember a six-digit number. So far, so good. The Walmart app recently asked me to verify my identity when I arrived for a grocery pickup order. Seriously? There are 32 pickup spots in the parking lot, and I was the only single solitary car out there. It was 7 a.m. and still dark. Yes, it’s me. Now please bring out the milk and laundry detergent. Of course, there’s always facial-recognition identification that simplifies logging in, but do I want to go down that road? What if I have a good night’s sleep (unlikely), the bags under my eyes disappear (virtually impossible) and the app can’t recognize me? What if I decide to have plastic surgery, have everything on my face pulled, tightened, puffed and fluffed, and wind up looking so young that the app doesn’t recognize me? That is also highly unlikely, but a woman of a certain age likes to keep her options open. The only thing I know for sure is that I always experience a wave of panic whenever I see the message: “Failed to verify your identity.” The upside of all this identity-verification business is that the CAPTCHA security checks that once required you to click on the all the boxes with power lines, bicycles or traffic lights now simply ask you to check the “I am not a robot” box. As improved as that is, I still believe that CAPTCHA should be renamed GOTCHA.Ifedi starts at left tackle for Browns in prime-time matchup against AFC North-leading Steelers
BOSTON--(BUSINESS WIRE)--Dec 8, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced longer-term data for CASGEVYTM (exagamglogene autotemcel) from global clinical trials in people with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). CASGEVY is the first and only approved CRISPR/Cas9 gene-edited therapy. The results, presented at the American Society of Hematology (ASH) Annual Meeting and Exposition, continue to demonstrate the transformative, durable clinical benefits of CASGEVY. The longest follow up for both SCD and TDT patients now extends more than 5 years, with a median of 33.2 months and 38.1 months, respectively. “These comprehensive data provide additional evidence of the benefits of eradicating transfusion requirements for people with transfusion-dependent beta thalassemia and vaso-occlusive crises for those with sickle cell disease,” said Franco Locatelli, M.D., Ph.D., Professor of Pediatrics at the Catholic University of the Sacred Heart of Rome, Director of the Department of Pediatric Hematology and Oncology at Bambino Gesù Children’s Hospital, Chair of Vertex’s TDT Program Steering Committee, and Presenting Author of the CASGEVY clinical data at ASH. “With median follow-up around three years there is strong evidence for the durability of these beneficial effects following treatment with CASGEVY.” “CASGEVY is changing the outlook for people living with sickle cell disease and beta thalassemia, with these data reinforcing the immense clinical value a durable one-time therapy can provide to patients,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer at Vertex. “We have a strong commitment to build on our progress in bringing CASGEVY to patients around the world.” New long-term follow-up data presented from the CASGEVY trials Vertex had seven abstracts accepted at the ASH annual meeting as outlined below: Progress in bringing CASGEVY to patients around the world CASGEVY is approved for both SCD and TDT in the U.S., the European Union, Great Britain, Canada, Switzerland, Bahrain and the Kingdom of Saudi Arabia, and Vertex plans to make submissions in the United Arab Emirates and Kuwait. More than 45 authorized treatment centers have been activated globally to support the delivery of CASGEVY, and more than 40 patients have had a first cell collection. Vertex is continuing to work with reimbursement authorities to secure sustainable access for patients. Through this work, Vertex has agreements to provide CASGEVY in multiple countries, including the U.S., England (TDT), Austria, Bahrain and the Kingdom of Saudi Arabia, and continues to make strong progress in others, including positive Health Technology Assessments (HTAs) in Canada for both diseases and advancing access negotiations for SCD patients in England. In the U.S., Vertex recently secured an industry-first, voluntary agreement with the Centers for Medicare & Medicaid Services (CMS) on a single outcomes-based arrangement available to all state Medicaid programs to ensure broad and equitable access to CASGEVY. To support this progress on patient access and growing patient demand, Vertex has received approval for a third manufacturing facility for CASGEVY with our partner Lonza. About Sickle Cell Disease (SCD) SCD is a debilitating, progressive and life-shortening disease. SCD patients report health-related quality of life scores well below the general population, and the lifetime health care costs in the U.S. of managing SCD for patients with recurrent VOCs is estimated between $4 and $6 million. SCD is an inherited blood disorder that affects the red blood cells, which are essential for carrying oxygen to all organs and tissues of the body. SCD causes severe pain, organ damage and shortened life span due to misshapen or “sickled” red blood cells. The clinical hallmark of SCD is VOCs, which are caused by blockages of blood vessels by sickled red blood cells and result in severe and debilitating pain that can happen anywhere in the body at any time. SCD requires a lifetime of treatment and results in a reduced life expectancy. In the U.S., the median age of death for patients living with SCD is approximately 45 years. A cure for SCD today is a stem cell transplant from a matched donor, but this option is only available to a small fraction of patients living with SCD because of the lack of available donors. About Transfusion-Dependent Beta Thalassemia (TDT) TDT is a serious, life-threatening genetic disease. TDT patients report health-related quality of life scores below the general population and the lifetime health care costs in the U.S. of managing TDT are estimated between $5 and $5.7 million. TDT requires frequent blood transfusions and iron chelation therapy throughout a person’s life. Due to anemia, patients living with TDT may experience fatigue and shortness of breath, and infants may develop failure to thrive, jaundice and feeding problems. Complications of TDT can also include an enlarged spleen, liver and/or heart, misshapen bones and delayed puberty. TDT requires lifelong treatment and significant use of health care resources, and ultimately results in reduced life expectancy, decreased quality of life and reduced lifetime earnings and productivity. In the U.S., the median age of death for patients living with TDT is 37 years. Stem cell transplant from a matched donor is a curative option but is only available to a small fraction of people living with TDT because of the lack of available donors. About CASGEVYTM (exagamglogene autotemcel [exa-cel]) CASGEVYTM is a non-viral, ex vivo CRISPR/Cas9 gene-edited cell therapy for eligible patients with SCD or TDT, in which a patient’s own hematopoietic stem and progenitor cells are edited at the erythroid specific enhancer region of the BCL11A gene through a precise double-strand break. This edit results in the production of high levels of fetal hemoglobin (HbF; hemoglobin F) in red blood cells. HbF is the form of the oxygen-carrying hemoglobin that is naturally present during fetal development, which then switches to the adult form of hemoglobin after birth. CASGEVY has been shown to reduce or eliminate VOCs for patients with SCD and transfusion requirements for patients with TDT. CASGEVY is approved for eligible SCD and TDT patients 12 years and older by multiple regulatory bodies around the world. About the CLIMB Trials The ongoing Phase 1/2/3 open-label trials, CLIMB-111 and CLIMB-121, are designed to assess the safety and efficacy of a single dose of CASGEVY in patients ages 12 to 35 years with TDT or with SCD and recurrent VOCs. The trials are closed for enrollment. Patients will be followed for approximately two years after CASGEVY infusion in these trials. Each patient will be asked to participate in the ongoing long-term, open-label trial, CLIMB-131. CLIMB-131 is designed to evaluate the long-term safety and efficacy of CASGEVY in patients who received CASGEVY, including those in other CLIMB trials. The trial is designed to follow patients for up to 15 years after CASGEVY infusion. U.S. INDICATIONS AND IMPORTANT SAFETY INFORMATION FOR CASGEVY (exagamglogene autotemcel) WHAT IS CASGEVY? CASGEVY is a one-time therapy used to treat people aged 12 years and older with: • sickle cell disease (SCD) who have frequent vaso-occlusive crises or VOCs • beta thalassemia (β-thalassemia) who need regular blood transfusions CASGEVY is made specifically for each patient, using the patient’s own edited blood stem cells, and increases the production of a special type of hemoglobin called hemoglobin F (fetal hemoglobin or HbF). Having more HbF increases overall hemoglobin levels and has been shown to improve the production and function of red blood cells. This can eliminate VOCs in people with sickle cell disease and eliminate the need for regular blood transfusions in people with beta thalassemia. IMPORTANT SAFETY INFORMATION What is the most important information I should know about CASGEVY? After treatment with CASGEVY, you will have fewer blood cells for a while until CASGEVY takes hold (engrafts) into your bone marrow. This includes low levels of platelets (cells that usually help the blood to clot) and white blood cells (cells that usually fight infections). Your doctor will monitor this and give you treatment as required. The doctor will tell you when blood cell levels return to safe levels. You may experience side effects associated with other medicines administered as part of the treatment regimen for CASGEVY. Talk to your physician regarding those possible side effects. Your healthcare provider may give you other medicines to treat your side effects. How will I receive CASGEVY? Your healthcare provider will give you other medicines, including a conditioning medicine, as part of your treatment with CASGEVY. It’s important to talk to your healthcare provider about the risks and benefits of all medicines involved in your treatment. After receiving the conditioning medicine, it may not be possible for you to become pregnant or father a child. You should discuss options for fertility preservation with your healthcare provider before treatment. STEP 1: Before CASGEVY treatment, a doctor will give you mobilization medicine(s). This medicine moves blood stem cells from your bone marrow into the blood stream. The blood stem cells are then collected in a machine that separates the different blood cells (this is called apheresis). This entire process may happen more than once. Each time, it can take up to one week. During this step rescue cells are also collected and stored at the hospital. These are your existing blood stem cells and are kept untreated just in case there is a problem in the treatment process. If CASGEVY cannot be given after the conditioning medicine, or if the modified blood stem cells do not take hold (engraft) in the body, these rescue cells will be given back to you. If you are given rescue cells, you will not have any treatment benefit from CASGEVY. STEP 2: After they are collected, your blood stem cells will be sent to the manufacturing site where they are used to make CASGEVY. It may take up to 6 months from the time your cells are collected to manufacture and test CASGEVY before it is sent back to your healthcare provider. STEP 3: Shortly before your stem cell transplant, your healthcare provider will give you a conditioning medicine for a few days in hospital. This will prepare you for treatment by clearing cells from the bone marrow, so they can be replaced with the modified cells in CASGEVY. After you are given this medicine, your blood cell levels will fall to very low levels. You will stay in the hospital for this step and remain in the hospital until after the infusion with CASGEVY. STEP 4: One or more vials of CASGEVY will be given into a vein (intravenous infusion) over a short period of time. After the CASGEVY infusion, you will stay in hospital so that your healthcare provider can closely monitor your recovery. This can take 4-6 weeks, but times can vary. Your healthcare provider will decide when you can go home. What should I avoid after receiving CASGEVY? What are the possible or reasonably likely side effects of CASGEVY? The most common side effects of CASGEVY include: Your healthcare provider will test your blood to check for low levels of blood cells (including platelets and white blood cells). Tell your healthcare provider right away if you get any of the following symptoms: These are not all the possible side effects of CASGEVY. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. General information about the safe and effective use of CASGEVY Talk to your healthcare provider about any health concerns. Please see full Prescribing Information including Patient Information for CASGEVY. About Vertex Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1. Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 15 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best Companies to Work For. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on LinkedIn , Facebook , Instagram , YouTube and X . (VRTX-GEN) Vertex Special Note Regarding Forward-Looking Statements This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, the statements by Franco Locatelli, M.D., Ph.D. and Carmen Bozic, M.D., in this press release, and statements regarding expectations for the anticipated transformative, durable clinical benefits of CASGEVY, plans to continue working with reimbursement authorities to secure sustainable access for patients, including our expectations for progress in Canada and England, and our plans for and design of the CLIMB studies. While we believe the forward-looking statements contained in this press release are accurate, these forward-looking statements represent the company's beliefs only as of the date of this press release and there are a number of risks and uncertainties that could cause actual events or results to differ materially from those expressed or implied by such forward-looking statements. Those risks and uncertainties include, among other things, that eligible patient access to CASGEVY may not be achieved on the anticipated timeline, or at all, that data from the company's development programs may not support registration or further development of its compounds due to safety, efficacy, and other reasons, and other risks listed under the heading “Risk Factors” in Vertex's most recent annual report and subsequent quarterly reports filed with the Securities and Exchange Commission at www.sec.gov and available through the company's website at www.vrtx.com . You should not place undue reliance on these statements, or the scientific data presented. Vertex disclaims any obligation to update the information contained in this press release as new information becomes available. View source version on businesswire.com : https://www.businesswire.com/news/home/20241206536804/en/ CONTACT: Vertex Pharmaceuticals Incorporated Investors: InvestorInfo@vrtx.comMedia : mediainfo@vrtx.com or International: +44 20 3204 5275 or U.S.: 617-341-6992 or Heather Nichols: +1 617-839-3607 KEYWORD: MASSACHUSETTS EUROPE UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH CLINICAL TRIALS SOURCE: Vertex Pharmaceuticals Incorporated Copyright Business Wire 2024. PUB: 12/08/2024 12:52 PM/DISC: 12/08/2024 12:50 PM http://www.businesswire.com/news/home/20241206536804/en Copyright Business Wire 2024.